Clinical trial
Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With Von Willebrand Disease (VWD)
NCT04052698 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With Von Willebrand Disease (VWD)
- Lead sponsor
- Octapharma
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 18, 2020
- Completion date
- April 23, 2022
- Enrollment
- 43 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.